These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29100323)

  • 21. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of that synergistic effect of cisplatin combined with compound herbal medicinal prescription for tonic quality and activating blood circulation is on SKOV3 cell proliferation and apoptosis].
    Suo YP; Wang BY; Hong Z; Yin RT; Wang DQ; Peng ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):542-6. PubMed ID: 16909597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro].
    He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
    Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3.
    Sun C; Yi T; Song X; Li S; Qi X; Chen X; Lin H; He X; Li Z; Wei Y; Zhao X
    Oncol Rep; 2011 Jul; 26(1):193-200. PubMed ID: 21519794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.
    Li D; Zhang Y; Xie Y; Xiang J; Zhu Y; Yang J
    Cancer Gene Ther; 2013 Apr; 20(4):251-9. PubMed ID: 23470565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild oxidative stress induced by a low dose of cisplatin contributes to the escape of TRAIL-mediated apoptosis in the ovarian cancer SKOV3 cell line.
    Lu J; Zhang L; Xie F; Zhu L; Li X; Ouyang J; He X; Han S; Yi C
    Oncol Rep; 2016 Jun; 35(6):3427-34. PubMed ID: 27035109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.
    Li L; Khan MN; Li Q; Chen X; Wei J; Wang B; Cheng JW; Gordon JR; Li F
    Oncol Rep; 2015 Feb; 33(2):751-7. PubMed ID: 25504010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo.
    Gu J; Tang Y; Liu Y; Guo H; Wang Y; Cai L; Li Y; Wang B
    Cancer Lett; 2014 Feb; 343(2):200-9. PubMed ID: 24161623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of Zengmian Yiliu Recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer].
    Qi C; Zhang QH; Li JX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):817-21. PubMed ID: 22978111
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
    World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
    Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
    Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [TRAIL impacts in growth and apoptosis of human ovarian carcinoma cell line SKOV3].
    Li CM; Peng ZL; Yin RT; Hu M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):761-4. PubMed ID: 17037746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella.
    Deng J; Guo Y; Jiang Z; Yang M; Li H; Wang J
    J Obstet Gynaecol Res; 2015 Apr; 41(4):615-22. PubMed ID: 25370788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
    Zou W; Ma X; Hua W; Chen B; Cai G
    Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapamycin-topotecan combination exhibited enhanced antitumor efficacy compared to topotecan used alone in cisplatin-resistant ovarian cancer cells.
    Sun G; Guo Z; Li X
    Neoplasma; 2015; 62(5):740-7. PubMed ID: 26278147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
    Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
    Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.